Patent · US Active

Pharmaceutical composition, methods for treating and uses thereof

US9192617B2 · kind B2 · utility

10Cited by

59References

14Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Eric Williams MAYOUX · Gambais, FR
Rolf GREMPLER · Mittelbiberach, DE
Thomas KLEIN · Radolfzell, DE

Key dates

Filing date	Mar 15, 2013
Grant date	Nov 24, 2015
Priority date	—
Expiry date	Apr 22, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02B70/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the treatment of metabolic disorders in an overweight or obese patient characterized in that empagliflozin and one or more antiobesity drugs are administered to the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.